Skip to Main Content
Center for Cancer ResearchCCR Home | About CCR | CCR Intranet

Headline Title

Cell & Molecular Biology Section: CMBS Staff

Zhijie Li, MD

A photo of Zhijie Li, MD
Zhijie Li, MD, Research Fellow

I graduated from China Medical University, China in 1990 and received my PhD degree in 2000. I began to work for the Cell and Molecular Biology Section in 2003. My research project focuses on delineating the mechanism by which activation of the BDNF/TrkB signal transduction pathway protect Neuroblastoma cells from chemotherapy. I've identified that the PI3K/Akt signaling pathway is a key pathway. Small molecular inhibitors targeting TrkB and Akt are being tested to improve the sensitivity of Neuroblastoma cells. These preclinical models have identified a potential new strategy to improve the effects of chemotherapy in children with neuroblastoma tumors.

Dashed Line

Zhijie's Data:

BDNF/TrkB pathway & NB cell response to cytotoxic agents

Dashed Line

return to the top

This Page Last Reviewed on February 26, 2013

About CCR | Clinical Trials | Research | Employment | Initiatives | News | Events | Site Privacy Policy | Accessibility

A Service of the National Cancer Institute

Department of Health and Human Services National Institutes of Health (NIH) USA Gov